By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Janssen Pharmaceutica N.V. 

Turnhoutseweg 30

Beerse  Antwerpen  2340  Belgium
Phone: 32-14602226 Fax:




Vertex  (telaprevir for HCV) - Europe, South America, Australia, the Middle East and other countries

Company News
Janssen Pharmaceutica N.V. Enters Exclusive Distribution Agreement For Invokana And Vokanamet In Selected European Economic Area Countries 9/5/2017 9:38:57 AM
Minerva Neurosciences (NERV) Announces European Commission (EC) Approval Of Amendment Of MIN-202 Agreement With Janssen Pharmaceutica N.V. 8/25/2017 8:18:34 AM
Janssen Pharmaceutica N.V. Promises Lung Cancer Drug Initiative In China 5/30/2017 2:11:26 PM
Genmab A/S (GEN.CO) Achieves USD 25 Million Sales Milestone In DARZALEX (Daratumumab) Collaboration With Janssen Pharmaceutica N.V. 1/9/2017 7:29:42 AM
Janssen Pharmaceutica N.V. Release: New Idylla Ebola Virus Triage Test Granted Emergency Use Authorization by U.S. FDA 6/1/2016 6:52:23 AM
Genometry Announces Deal With Janssen Pharmaceutica N.V. For Library-Scale Gene-Expression Profiling 10/8/2015 11:41:26 AM
Royal Philips Electronics N.V. (PHG) Enters Into Collaboration With Janssen Pharmaceutica N.V. To Develop New Handheld Blood Test To Support Care Of Patients With Neuropsychiatric Disorders 3/25/2015 1:56:23 PM
Galapagos (GLPG.BR) Ends Long-Running R&D Inflammation Pact With Janssen Pharmaceutica N.V. 3/17/2015 6:07:57 AM
EB Pharma Announces License Agreement For Investigational Drug, Tipifarnib From Janssen Pharmaceutica N.V. For Development In Hepatitis Delta Virus (HDV) Infection 12/23/2014 7:51:48 AM
Galapagos NV (GLPG.BR) Initiates Phase 1 Study With GLPG1690, Triggering €6.6 M Milestone In The Alliance With Janssen Pharmaceutica N.V. 7/1/2014 9:13:37 AM